Outbreak of Burkholderia cepacia bacteremia in immunocompetent children caused by contaminated nebulized sulbutamol in Saudi Arabia

American Journal of Infection Control

Volumn 34, Issue 6, 2006, Pages 394-398

  Ghazal, Sameeh S ^a   Al Mudaimeegh, Khaled ^a   Al Fakihi, Elham Mohammed ^a   Asery, Ali Talee ^a  

^a KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; HYDROCORTISONE; SALBUTAMOL; VINTEC;

ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BURKHOLDERIA CEPACIA; CHRONIC DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG CONTAMINATION; EPIDEMIC; FEMALE; HUMAN; IMMUNOCOMPETENCE; INFANT; INFECTION CONTROL; INFECTION RISK; MALE; NEBULIZER; PHYSICIAN; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; SAUDI ARABIA; STATISTICAL SIGNIFICANCE; VIRUS INFECTION;

ALBUTEROL; BRONCHODILATOR AGENTS; BUDESONIDE; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; DRUG COMBINATIONS; DRUG CONTAMINATION; FEMALE; HUMANS; IMMUNOCOMPETENCE; INFANT; MALE; NEBULIZERS AND VAPORIZERS; SAUDI ARABIA;

EID: 33746323033     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2006.03.003     Document Type: Article

References (13)

1. Pickering L.K. Red book (Report of the committee on Infectious Diseases. American Academy of Pediatrics): Burkhulderia cepacia. 25th ed. (2003), APP, Elk Grove Village, IL p. 224-5
2. Jones A.M., Dodd M.E., and Webb A.K. Burkholderia cepacia, current clinical issues, environmental controversies and ethical dilemmas. Eur Respir J 17 (2001) 295-301
3. Chen J.S., Witzmann K.A., Spilker T., Fink R.J., and Li Puma J.J. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 139 (2001) 643-649
4. Bureau-Chalot F., Piednoir E., Pierrat C., Santerne B., and Bajolet O. Nosocomial Burkholderia cepacia outbreak in an intensive pediatric care unit. Arch Pediatr 10 (2003) 882-886
5. Loukil C., Saizou C., Doit C., Bidet P., Mariani-Kurkdjian P., Aujard Y., et al. Epidemiologic investigation of Burkholderia cepacia acquisition in two pediatric intensive care units. Infect Control Hosp Epidemiol 24 (2003) 707-710
6. Siddiqui A.H., Mulligan M.E., Mahenthiralingam E., Hebden J., Brewrink J., Qaiyumi S., et al. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital. Infect Control Hosp Epidemiol 22 (2001) 419-422
7. Belchis D.A., Simpson E., and Colby T. Histopathologic features of Burkholderia cepacia pneumonia in patients without cystic fibrosis. Mod Pathol 13 (2000) 369-372
8. Walsh N.M., Casano A.A., Manangan L.P., Sinkowitz-Cochran R.L., and Jarvis W.R. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis. J Pediatr 141 (2002) 512-517
9. Speert D.P. Advances in Burkholderia cepacia complex. Paediatr Respir Rev 3 (2002) 230-235
10. Ishizuka T., Oyama T., Sato M., Hisada T., Takagi H., Hamada T., et al. Fatal pneumonia caused by Burkholderia cepacia 9 months after resection of aspergilloma. [in process citation]. Respirology 8 (2003) 401-403
11. Manno G., Ugolotti E., Belli M.L., Fenu M.L., Romano L., and Cruciani M. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 22 (2003) 28-34
12. Zhang L., Li X.Z., and Poole K. Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia. J Antimicrob Chemother 48 (2001) 549-552
13. Huang C.H., Jang T.N., Liu C.Y., Fung C.P., Yu K.W., and Wong W.W. Characteristics of patients with Burkholderia cepacia bacteremia. J Microbiol Immunol Infect (China) 34 (2001) 215-219